Data are a part of an ongoing longitudinal study and are unsuitable for public deposition due to ethical restrictions. Data are available upon request to the corresponding author.

Introduction {#sec005}
============

The immigration of Japanese people to the Hawaiian Islands began during the latter half of the 19th century. The lifestyle, including diet and amount of exercise, differed greatly between Japan and the United States at that time. Upon arrival in the United States, the lifestyles of many such Japanese immigrants underwent rapid westernization. Because Japanese-Americans, while genetically equivalent to native Japanese, have a considerably more westernized lifestyle, they are an appropriate population for investigating the effects of a westernized lifestyle on the incidence of metabolic diseases among Japanese individuals.

In 1970, we began to conduct a medical survey of Japanese-Americans in an epidemiological study called "the Hawaii---Los Angeles---Hiroshima Study" \[[@pone.0120804.ref001]\]. Since then, these surveys have been conducted every few years in Hawaii or Los Angeles, now totaling 23 times, and by the end of 2014 had included over 12,700 participants. We compared Japanese who reside in Japan and follow a Japanese lifestyle with Japanese-Americans who reside in the United States and follow a westernized lifestyle. Level of obesity was significantly greater in Japanese-Americans than in Japanese living in Hiroshima \[[@pone.0120804.ref002]\], as was the prevalence of type 2 diabetes \[[@pone.0120804.ref003], [@pone.0120804.ref004]\] and metabolic syndrome (MS) \[[@pone.0120804.ref005]\]. Furthermore, Japanese-Americans showed more rapidly progressing atherosclerosis than did native Japanese \[[@pone.0120804.ref006]\].

Few studies have described whether childhood lifestyle has a strong effect on the future development of obesity and diabetes mellitus \[[@pone.0120804.ref007]--[@pone.0120804.ref009]\]. In this study, Japanese-Americans were divided into two groups: those who were born and grew up in Japan and later emigrated to the United States (termed "first-generation Japanese-Americans"), and those who were born and grew up in the United States (termed "second- or later-generation Japanese-Americans"). Moreover, the second- or later-generation Japanese-Americans can be further subdivided into individuals who were born in the United States and grew up there, and individuals who were born in the United States but had an experience that living and being educated in Japan during their childhood and adolescence and then returning to the United States (termed the "*kibei* subgroup" \["*kibei*" is the Japanese term for "return to the United States"\]). We hypothesized that the incidence of lifestyle-related diseases in people growing up with a Japanese lifestyle would be lower than in people growing up with a westernized lifestyle by generation or having *kibei* experience among Japanese-Americans.

The objective of this study was to determine whether a Japanese lifestyle during childhood would act as a buffer against the development of obesity and metabolic diseases. We compared the prevalence of obesity and metabolic diseases among four groups: native Japanese, first-generation Japanese-Americans, and second- or later-generation Japanese-Americans divided by *kibei* experience (*kibei* subgroup: resided in Japan during childhood and returned to the United States; non-*kibei* subgroup: grew up in the United States).

Methods {#sec006}
=======

Subjects {#sec007}
--------

Japanese and Japanese-Americans whose parents were both Japanese had participated in the medical survey, excluding potential participants below the age of 30 years or with a mixed ethnic background. The subjects of this study were 221 Japanese-Americans (132 men and 89 women) living in Hilo and Kona, on the Island of Hawaii in 2007; 560 Japanese-Americans (237 men and 323 women) living in Los Angeles, California in 2010; and 516 native Japanese (171 men and 345 women) living in Hiroshima in 2009. Japanese-Americans comprised 56.9% first-generation individuals, 18.1% second-generation, 22.1% third-generation, 2.8% fourth-generation, and 0.1% fifth-generation. We combined the second-, third-, fourth-, and fifth-generation into "second- or later- generations". The first-generation Japanese-Americans and the second- or later-generation Japanese-Americans were abbreviated as "JA-1" and "JA-2", respectively, in this study. Within JA-2, Japanese-Americans who moved to Japan before the age of 18 and stayed for at least five years were classified as the *kibei* subgroup, and individuals who had never lived in Japan were defined as the non-*kibei* subgroup. JA-2 consisted of 79 *kibei* (42 men and 37 women) and 258 non-*kibei* (153 men and 105 women). JA-2 who had lived in Japan during childhood for less than 5 years or moved to Japan after the age of 19 years were excluded from the analysis.

Due to a significant difference in average age between native Japanese, JA-1, and JA-2, study participants were separated into three age groups: 30--49 years, 50--69 years, and ≥ 70 years old. When we compared the *kibei* subgroup with the non-*kibei* subgroup, due to the small number of JA-2 participants in the 30--49 age group, JA-2 was separated into two age groups incorporating the 50--69 category: \< 70 years old and ≥ 70 years old.

All subjects provided their written informed consent to participate in the examinations. This study was approved by the ethics committee of Hiroshima University and the Councils of the Hiroshima Kenjin-Kai Association in Hawaii and Los Angeles.

Measurements {#sec008}
------------

Medical examinations took place in the morning after an overnight fast. Each subject completed an interview, physical and blood pressure (BP) measurements, and venous blood sampling. Waist circumference was measured at the level of the umbilicus. Body mass index (BMI) was calculated by dividing weight (kg) by height squared (m^2^). An oral glucose tolerance test (OGTT) was performed on subjects without diabetes. Each blood sample was centrifuged, and the obtained serum samples were immediately frozen and stored until analysis. Serum glucose levels were measured by the hexokinase method; insulin levels by double-antibody radioimmunoassay; total cholesterol and triglyceride levels by an enzymatic method; and high-density lipoprotein (HDL) cholesterol levels by homogenous assay.

Diagnostic criteria {#sec009}
-------------------

The definitions for obesity, MS, and diabetes were as follows. Obesity was defined as BMI ≥ 25 kg/m^2^ \[[@pone.0120804.ref010]\].

MS was diagnosed according to International Diabetes Federation criteria \[[@pone.0120804.ref011]\]. These criteria include an essential component of central obesity (a waist circumference ≥ 90 cm in men and ≥ 80 cm in women). Individuals require two or more of the following four factors in addition to central obesity. The first component is raised BP (systolic BP ≥ 130 mmHg and/or diastolic BP ≥ 85 mmHg) or treatment of previously diagnosed hypertension. The second component is raised triglycerides level (≥ 150 mg/dl) or specific treatment for this lipid abnormality. The third component is reduced HDL cholesterol level (\< 40 mg/dl in men and \< 50 mg/dl in women), or specific treatment for this lipid abnormality. The final component is raised fasting glucose level (≥ 100 mg/dl) or treatment of previously diagnosed type 2 diabetes.

Diabetes was diagnosed as fasting glucose level ≥ 126 mg/dl and/or two-hour post-load (2-h) glucose level ≥ 200 mg/dl after an OGTT \[[@pone.0120804.ref012]\], or as treatment of previously diagnosed diabetes.

Statistical analysis {#sec010}
--------------------

Values are expressed as numbers, means ± SD, medians (25th--75th percentile levels), or percentages. Fasting glucose, 2-h glucose, fasting insulin, homeostasis model assessment-insulin resistance (HOMA-IR) \[[@pone.0120804.ref013]\], and triglycerides were analyzed after logarithmic transformation, because distributions of these parameters were skewed. Mean differences among the groups were tested by a multiple regression analysis or an ANCOVA, adjusting for age and sex, followed by the Bonferroni multiple comparison test. *χ* ^2^ test was used to evaluate frequency differences among the groups. A *P*-value of \< 0.05 was considered statistically significant. Statistical analyses were performed with the software packages SPSS version 19.0 (IBM Corp., Armonk, NY) and SAS version 8.2 (SAS Institute, Cary, NC).

Results {#sec011}
=======

Comparison of native Japanese and Japanese-Americans by generation {#sec012}
------------------------------------------------------------------

[Table 1](#pone.0120804.t001){ref-type="table"} shows the demographic and medical characteristics of this study's subjects. For JA-1, the average age at immigration to the United States was 27.0 ± 8.4 years old, with the mean duration of stay in the United States being 35.5 ± 14.1 years. BMI was significantly higher in JA-2 than in both native Japanese and JA-1. Waist circumference was significantly higher in native Japanese and JA-2 than in JA-1. Among men, waist circumference did not differ significantly among the three groups. On the other hand, among women, waist circumference was significantly higher in native Japanese and JA-2 than in JA-1. Systolic BP was significantly higher in JA-1 than in native Japanese. Diastolic BP was significantly higher in JA-1 than in native Japanese and JA-2. No significant difference was observed in fasting glucose level and 2-h glucose level, but fasting insulin level and HOMA-IR were significantly higher in JA-1 than in native Japanese. Furthermore, those values were significantly higher in JA-2 than in JA-1. Total cholesterol level was significantly lower in JA-2 than in native Japanese and JA-1. Triglycerides were significantly higher in both JA-1 and JA-2 than in native Japanese. Compared with native Japanese and JA-1, JA-2 had a significantly higher rate of treatment for hypertension, dyslipidemia, and diabetes.

10.1371/journal.pone.0120804.t001

###### Characteristics of study subjects.

![](pone.0120804.t001){#pone.0120804.t001g}

                             Japanese               Japanese-Americans                                          
  -------------------------- ---------------------- ----------------------------------------------------------- ----------------------------------------------------------------------------------------------
  N (Men/Women)              516 (171/345)          444 (174/270)                                               337 (195/142)
  Age, years                 60.4 ± 12.8            62.4 ± 11.8[^a^](#t001fn004){ref-type="table-fn"}           68.0 ± 14.2[^b^](#t001fn005){ref-type="table-fn"} [^c^](#t001fn006){ref-type="table-fn"}
  BMI, kg/m^2^               23.0 ± 3.2             23.3 ± 3.1                                                  24.8 ± 4.2[^b^](#t001fn005){ref-type="table-fn"} [^c^](#t001fn006){ref-type="table-fn"}
  Waist circumference, cm    83.6 ± 9.1             79.8 ± 10.3[^a^](#t001fn004){ref-type="table-fn"}           86.1 ± 11.8[^c^](#t001fn006){ref-type="table-fn"}
   Men, cm                   86.2 ± 7.8             85.2 ± 8.7                                                  87.6 ± 11.2
   Women, cm                 82.3 ± 9.5             76.4 ± 9.7[^a^](#t001fn004){ref-type="table-fn"}            84.0 ± 12.4[^c^](#t001fn006){ref-type="table-fn"}
  Systolic BP, mmHg          127.0 ± 18.1           133.3 ± 18.9[^a^](#t001fn004){ref-type="table-fn"}          134.8 ± 17.7
  Diastolic BP, mmHg         77.8 ± 11.0            82.7 ± 11.0[^a^](#t001fn004){ref-type="table-fn"}           77.1 ± 10.4[^c^](#t001fn006){ref-type="table-fn"}
  Fasting glucose, mg/dl     93.0 (88.0--99.0)      91.0 (85.0--100.0)                                          92.0 (86.0--101.0)
  2-h glucose, mg/dl         119.0 (102.0--144.0)   113.0 (94.0--144.0)                                         125.0 (99.0--157.0)
  Fasting insulin, μU/ml     4.0 (3.2--5.9)         5.1 (3.5--10.0)[^a^](#t001fn004){ref-type="table-fn"}       6.1 (3.7--13.5)[^b^](#t001fn005){ref-type="table-fn"} [^c^](#t001fn006){ref-type="table-fn"}
  HOMA-IR                    0.9 (0.7--1.5)         1.2 (0.8--2.3)[^a^](#t001fn004){ref-type="table-fn"}        1.5 (0.8--3.3)[^b^](#t001fn005){ref-type="table-fn"} [^c^](#t001fn006){ref-type="table-fn"}
  Total cholesterol, mg/dl   209.3 ± 33.0           210.0 ± 41.8                                                198.7 ± 38.9[^b^](#t001fn005){ref-type="table-fn"} [^c^](#t001fn006){ref-type="table-fn"}
  HDL cholesterol, mg/dl     62.5 ± 14.4            61.3 ± 16.5                                                 63.8 ± 16.7[^b^](#t001fn005){ref-type="table-fn"} [^c^](#t001fn006){ref-type="table-fn"}
  Triglycerides, mg/dl       91.0 (66.0--125.0)     115.0 (80.0--168.8)[^a^](#t001fn004){ref-type="table-fn"}   110.0 (77.0--166.0)[^b^](#t001fn005){ref-type="table-fn"}
  Treatment for                                                                                                 
   hypertension, %           20.2                   31.3[^a^](#t001fn004){ref-type="table-fn"}                  43.6[^b^](#t001fn005){ref-type="table-fn"} [^c^](#t001fn006){ref-type="table-fn"}
   dyslipidemia, %           21.3                   22.3                                                        37.4[^b^](#t001fn005){ref-type="table-fn"} [^c^](#t001fn006){ref-type="table-fn"}
   type 2 diabetes, %        8.3                    9.5                                                         15.4[^b^](#t001fn005){ref-type="table-fn"} [^c^](#t001fn006){ref-type="table-fn"}
  Current smoking, %         11.4                   14.4                                                        8.0[^c^](#t001fn006){ref-type="table-fn"}
  Alcohol drinking, %        29.1                   27.8                                                        19.7[^b^](#t001fn005){ref-type="table-fn"} [^c^](#t001fn006){ref-type="table-fn"}

JA-1, first-generation Japanese-Americans; JA-2, second- or later-generation Japanese-Americans; BMI, body mass index; BP, blood pressure; 2-h, two-hour post-load; HOMA-IR, homeostasis model assessment-insulin resistance; HDL, high-density lipoprotein.

Values are expressed as numbers, means ± SD, medians (25th--75th percentile levels), or percentages.

The parameters were analyzed after adjusting for age and sex.

^a^ *P* \< 0.05 between Japanese and JA-1.

^b^ *P* \< 0.05 between Japanese and JA-2.

^c^ *P* \< 0.05 between JA-1 and JA-2.

The prevalence of obesity, MS, and type 2 diabetes among native Japanese and Japanese-Americans by generation is shown in [Table 2](#pone.0120804.t002){ref-type="table"}. There was a significant trend of increasing obesity rates among native Japanese, JA-1, and JA-2, in that order. We observed a similar trend among both men and women and among all age groups. There was a significant trend of increasing prevalence of MS among native Japanese, JA-1, and JA-2. We observed a similar trend among men and women. There was a significant trend among the age groups of 30--49 years and ≥ 70 years old. The prevalence of type 2 diabetes was 12.2%, 18.9%, and 22.0% for native Japanese, JA-1, and JA-2, respectively. There was a significant trend among all subjects, both men and women. We observed a significant trend among the age group of ≥ 70 years old.

10.1371/journal.pone.0120804.t002

###### Prevalence of obesity, metabolic syndrome, and type 2 diabetes among native Japanese and Japanese-Americans by generation

![](pone.0120804.t002){#pone.0120804.t002g}

                    Obesity   Metabolic syndrome   Type 2 diabetes                                                                   
  ----------------- --------- -------------------- ----------------- ---------- ------ ------ ------ ---------- ------ ------ ------ ---------
  All, %            25.2      28.6                 43.6              \< 0.001   24.0   22.3   38.0   \< 0.001   12.2   18.9   22.0   \<0.001
  Men, %            30.4      39.7                 44.1              0.008      19.9   20.1   32.8   0.003      14.0   24.7   24.6   0.016
  Women, %          22.6      21.5                 43.0              \< 0.001   26.1   23.7   45.1   0.001      11.3   15.2   18.3   0.033
  30--49 years, %   25.7      21.7                 48.8              0.019      11.9   11.7   30.2   0.014      5.5    3.3    14.0   0.127
  50--69 years, %   26.9      30.6                 51.8              \< 0.001   28.8   22.4   42.1   0.077      13.7   18.8   20.2   0.073
  ≥ 70 years, %     21.3      27.9                 37.2              0.002      24.3   27.1   37.2   0.011      14.7   26.4   25.0   0.039

JA-1, first-generation Japanese-Americans; JA-2, second- or later-generation Japanese-Americans.

Comparison of the *kibei* and non-*kibei* subgroups {#sec013}
---------------------------------------------------

The characteristics of the JA-2 generations by *kibei* status are shown in [Table 3](#pone.0120804.t003){ref-type="table"}. For the *kibei* subgroup, the average age at arrival in Japan was 4.3 ± 4.1 years old and that at departure from Japan was 18.8 ± 5.3 years, with the mean duration of stay in Japan being 14.9 ± 5.8 years (minimum duration of 5 years and maximum duration of 33 years). The *kibei* subgroup was significantly older and had higher diastolic BP than the non-*kibei* subgroup. Although BMI in the non-*kibei* was higher, but not significantly so, than in the *kibei* subgroup, the non-*kibei* had significantly higher waist circumference than the *kibei* subgroup. There were no significant differences between subgroups on fasting insulin level and HOMA-IR. Rate of treatment for hypertension, dyslipidemia, and diabetes were not significantly different.

10.1371/journal.pone.0120804.t003

###### Characteristics of the JA-2 generations by *kibei* status.

![](pone.0120804.t003){#pone.0120804.t003g}

                             *Kibei*               Non-*kibei*
  -------------------------- --------------------- ----------------------------------------------------------
  N (Men/Women)              79 (42/37)            258 (153/105)
  Age, years                 72.1 ± 11.0           66.8± 14.9[^a^](#t003fn005){ref-type="table-fn"}
  BMI, kg/m^2^               23.9 ± 3.7            25.1 ± 4.3
  Waist circumference, cm    82.7 ± 11.5           87.1 ± 11.7[^a^](#t003fn005){ref-type="table-fn"}
  Men                        85.3 ± 9.9            88.2 ± 11.5
  Women                      79.9 ± 12.7           85.5 ± 11.9
  Systolic BP, mmHg          133.6 ± 17.3          135.3 ± 17.8
  Diastolic BP, mmHg         80.6 ± 10.5           76.0 ± 10.1[^a^](#t003fn005){ref-type="table-fn"}
  Fasting glucose, mg/dl     91.0 (84.0--98.0)     93.0 (86.0--103.0)[^a^](#t003fn005){ref-type="table-fn"}
  2-h glucose, mg/dl         127.5 (97.0--164.3)   124.5 (99.5--153.8)
  Fasting insulin, μU/ml     6.2 (3.7--13.8)       6.0 (3.7--13.5)
  HOMA-IR                    1.3 (0.8--3.0)        1.5 (0.8--3.4)
  Total cholesterol, mg/dl   197.7 ± 42.2          199.0 ± 37.9
  HDL cholesterol, mg/dl     60.4 ± 16.0           64.8 ± 16.8[^a^](#t003fn005){ref-type="table-fn"}
  Triglycerides, mg/dl       106.0 (73.0--165.0)   112.5 (78.0--166.0)
  Treatment for                                    
  hypertension, %            46.8                  42.6
  dyslipidemia, %            35.4                  38.0
  type 2 diabetes, %         15.2                  15.5
  Current smoking, %         24.4                  18.3
  Alcohol drinking, %        10.1                  7.4

BMI, body mass index; BP, blood pressure; 2-h, two-hour post-load; HOMA-IR,

homeostasis model assessment-insulin resistance; HDL, high-density lipoprotein.

Values are expressed as numbers, means ± SD, medians (25th--75th percentile levels), or percentages.

The parameters were analyzed after adjusting for age and sex.

^a^ *P* \< 0.05 between *kibei* and non-*kibei*.

The prevalence of obesity, MS, and type 2 diabetes among the JA-2 generation by *kibei* status is shown in [Table 4](#pone.0120804.t004){ref-type="table"}. We found the prevalence of obesity and MS in the non-*kibei* to be significantly higher than that in the *kibei* subgroup. The prevalence of type 2 diabetes in the non-*kibei* was higher, but not significantly so, than that in the *kibei* subgroup. According to gender, the rates of obesity, MS, or diabetes in the non-*kibei* were higher than in the *kibei* subgroup both in men and women but not significantly so. There were no significant differences in the rates of obesity, MS, or diabetes between groups under the age of 70. For those over 70 years, however, the rates of obesity and MS in the non-*kibei* were significantly higher than in the *kibei* subgroup, with the same (non-significant) tendency for type 2 diabetes.

10.1371/journal.pone.0120804.t004

###### Prevalence of obesity, metabolic syndrome, and type 2 diabetes among the JA-2 generations by *kibei* status.

![](pone.0120804.t004){#pone.0120804.t004g}

                   Obesity   Metabolic syndrome   Type 2 diabetes                                       
  ---------------- --------- -------------------- ----------------- ------ ------ ------- ------ ------ -------
  All, %           31.6      47.3                 0.014             26.6   41.5   0.017   19.0   22.9   0.466
  Men, %           33.3      47.1                 0.113             21.4   35.9   0.076   21.4   25.5   0.588
  Women, %         29.7      47.6                 0.059             32.4   49.5   0.072   19.0   16.2   0.702
  \< 70 years, %   48.3      51.6                 0.749             34.5   39.8   0.593   24.1   17.2   0.384
  ≥ 70 years, %    22.0      43.9                 0.009             22.0   43.1   0.009   16.0   28.5   0.084

Discussion {#sec014}
==========

The present study is unique in revealing that temporary residence in Japan during childhood had a protective effect against the development of obesity and metabolic diseases, despite the increased prevalence of obesity in Japanese-Americans due to living a westernized lifestyle. Native Japanese, first-generation Japanese-Americans, and second- or later-generation Japanese-Americans (individuals in both the *kibei* and non-*kibei* groups) were separated by birthplace, growing up place, and living place (between Japan and the United States). Intriguingly, they had significantly different prevalence rates of obesity and metabolic diseases, which were caused by their different lifestyles in childhood.

In this 2007 to 2010 study, as in our previous reports, Japanese-Americans had a significantly higher prevalence of obesity, MS, and type 2 diabetes than did native Japanese \[[@pone.0120804.ref002]--[@pone.0120804.ref005]\]. Furthermore, we found that the longer Japanese-Americans had been exposed to a westernized lifestyle, the more likely they were to develop obesity and metabolic diseases by generational comparison of native Japanese and Japanese-Americans. Place of birth and the length of time spent in the United States among Asian-American immigrants were correlated with increased risks of obesity and diabetes \[[@pone.0120804.ref014], [@pone.0120804.ref015]\], which was consistent with our earlier report. We previously reported that the consumption of animal protein, animal fat, and simple carbohydrates increased across groups in order of native Japanese, JA-1, and JA-2, in spite of equal total energy intake among the three groups in the 1990s \[[@pone.0120804.ref016]\]. It is conceivable that the generational differences of prevalence of obesity and lifestyle-related diseases were significantly attributable to dietary acculturation across generations among Japanese-Americans.

Another interesting result from our study is that the prevalence of obesity and MS in the *kibei* subgroup was lower than that in the non-*kibei* subgroup, and more similar to that of JA-1, regardless of generation (as shown in Tables [2](#pone.0120804.t002){ref-type="table"} and [4](#pone.0120804.t004){ref-type="table"}). Because childhood and adolescent lifestyle affected dietary patterns \[[@pone.0120804.ref017]\] and physical activity \[[@pone.0120804.ref018]\] even into adulthood, early lifestyle could be associated with the risks of the development of obesity and diabetes in later life \[[@pone.0120804.ref007]--[@pone.0120804.ref009]\]. Hankin et al. showed that Japanese-Americans who had lived in Japan during childhood (the so-called *kibei* subgroup) tended to routinely eat Japanese food compared with second-generation Japanese-Americans who had never lived in Japan (the so-called non-*kibei* subgroup) \[[@pone.0120804.ref019]\]. These reports suggested that the JA-1 generation and the *kibei* subgroup consumed a Japanese diet and were physically active during childhood in Japan, and maintained a Japanese lifestyle throughout their lifetime even after their return to the United States. As a result, they might be protected against developing obesity and MS in their later years.

On the other hand, there was no significant difference in the prevalence of type 2 diabetes between the *kibei* and the non-*kibei* subgroups. We previously reported that high HOMA-IR values were useful for predicting the development of type 2 diabetes among Japanese-Americans \[[@pone.0120804.ref020]\]. Visceral adiposity is also known as a strong risk factor predicting the development of glucose intolerance \[[@pone.0120804.ref021]\] and diabetes \[[@pone.0120804.ref022]\] in Japanese-Americans. We found that HOMA-IR in Japanese-Americans was higher than in native Japanese, but there was no significant difference between the *kibei* and the non-*kibei* subgroups. This result supports the idea that the incidence of diabetes in Japanese individuals, unlike that of obesity and MS, is mainly attributable to insulin resistance and aging rather than lifestyle during childhood \[[@pone.0120804.ref023]\].

This study has several limitations. The primary among them was the limited number of participants. We were not able to separate individuals into narrower age categories (per 10 years), and the gender distribution significantly differed among Japanese, JA-1, and JA-2. Moreover, due to the small number of young *kibei* subgroup participants, we combined them into the age group of \< 70 years old. As a result, in the \< 70 years age group, the *kibei* subgroup was significantly older than the non-*kibei* subgroup, and therefore the *kibei* subgroup might have had a conversely higher prevalence of type 2 diabetes than the non-*kibei* subgroup. Second, the questionnaire items were insufficient for clarifying the background characteristics of each group. We did not evaluate diet, physical activity, and socioeconomic status, which would affect the development of obesity and lifestyle-related diseases according to both of generation and *kibei* status. Finally, the background characteristics of JA-1 were rather varied. Many young Japanese-Americans who had recently migrated from Japan to the United States were included in JA-1, which may explain the lack of a difference in the prevalence of obesity and MS between native Japanese and JA-1.

Conclusions {#sec015}
===========

We demonstrated that Japanese lifestyle during childhood was associated with a lower likelihood of developing obesity and MS among Japanese-Americans. Our findings suggest the possible importance of a traditional Japanese lifestyle in preventing the incidence of obesity-associated metabolic diseases.

This survey was supported by the members of the Hiroshima Kenjin-Kai Associations of Hilo, Kona, Hawaii and Los Angeles, California. We are indebted to Drs. Kazufumi Ishida and Yuji Usui from the Hiroshima General Hospital for the sample assays. We also thank Dr. Masamichi Okubo for his recommendations and advice on this manuscript.

[^1]: **Competing Interests:**Dr. Yamane was a former head of the authors\' department by May 2011, and belongs to Nippon Telegraph and Telephone (NTT) West Corporation Chugoku Health Administration Center currently. Thus, the authors do not receive any support from NTT West Corporation. This does not alter their adherence to PLOS ONE policies on sharing data and materials.

[^2]: Conceived and designed the experiments: MY. Performed the experiments: MS. Analyzed the data: SN. Wrote the paper: MS. Collected the data: MS. Wrote the first draft of the manuscript: MS. Reviewed and critically revised the manuscript: MY. Critically revised the manuscript for important intellectual content: KO KY NK.

[^3]: Current address: Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan

[^4]: Current address: Nippon Telegraph and Telephone (NTT) West Corporation Chugoku Health Administration Center, Hiroshima, Japan
